| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/01/2002 | US20020102711 Polypeptide for use in the treatment of cancer and immunological |
| 08/01/2002 | US20020102710 Polypeptide for use in the treatment of cancer, autoimmune diseases and inflammation |
| 08/01/2002 | US20020102702 Enzymatic polypeptide for use in the detergents |
| 08/01/2002 | US20020102701 licD1 |
| 08/01/2002 | US20020102700 metK |
| 08/01/2002 | US20020102691 Enzymatic polypeptide for use in treatment and prevention of, heart liver and inflammatory disorders |
| 08/01/2002 | US20020102688 Nucleotide sequences coding polypeptide for use as anticoagulant and antiseptic |
| 08/01/2002 | US20020102684 Human phospholipase inhibitor |
| 08/01/2002 | US20020102680 Nucleotide sequences coding enzymatcic polypeptide for use in paper making and cleaning contact lenses |
| 08/01/2002 | US20020102676 Nucleotide sequences coding membrane proteins for use in cancer therapy |
| 08/01/2002 | US20020102660 Method for synthesis of nucleic acids |
| 08/01/2002 | US20020102649 Human transport protein homologs |
| 08/01/2002 | US20020102645 Novel member of the lysyl oxidase gene family |
| 08/01/2002 | US20020102643 Dorsal tissue affecting factor and compositions |
| 08/01/2002 | US20020102638 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases, genetic disorders and cancer |
| 08/01/2002 | US20020102634 Human stanniocalcin-alpha |
| 08/01/2002 | US20020102629 Tissue-based water quality biosensors for detecting chemical warfare agents |
| 08/01/2002 | US20020102628 Catabolite repression control (Crc) gene and pseudomonas virulence |
| 08/01/2002 | US20020102627 Detecting bacterial infections of the urogenital system; obtain sample of body fluid, measure amount of trimethylamine, putrescine and cadaverine in sample, compare to control, evaluate for bacterial infection |
| 08/01/2002 | US20020102626 New atpase assay |
| 08/01/2002 | US20020102625 Apparatus for use in the detection of preferential particles in sample |
| 08/01/2002 | US20020102624 Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes |
| 08/01/2002 | US20020102619 Heparanase specific molecular probes and their use in research and medical applications |
| 08/01/2002 | US20020102618 Drosophila derived receptors of the steroid receptor superfamily |
| 08/01/2002 | US20020102614 Detecting muscular disorder in humans; obtain sample tissue, measure zinc finger proteins, compare to control, evaluate for muscular disorder |
| 08/01/2002 | US20020102604 Full-length human cDNAs encoding potentially secreted proteins |
| 08/01/2002 | US20020102602 Polypeptide for use as an antitumor agent |
| 08/01/2002 | US20020102600 Analzing preferential nucleotide sequences; obtain nucleotide sequences, incubate with primers bound to solid support, amplify, incubate with oligonucleotide probes, recover amplification poducts |
| 08/01/2002 | US20020102599 Detecting nucleotide sequence ligands; obtain nucleotide sequences, incubate with target, irradiate complexes, separate crosslinked nucleic acid-target complexes, detect complexes |
| 08/01/2002 | US20020102598 Apparatus for use in the manipulation and imaging biological samples |
| 08/01/2002 | US20020102596 Methods for detecting interaction of molecules with surface-bound reagents |
| 08/01/2002 | US20020102595 Methods for detection of incorporation of a nucleotide onto a nucleic acid primer |
| 08/01/2002 | US20020102594 Detecting amyloid plaques in brain tissue; obbtain brain tissue, incubate with fluorescent dye, detec fluorescence, in brain tissue |
| 08/01/2002 | US20020102593 Sequencing nucleic acid molecule; generate sequence reaction mixture, amplify, incubate with membranes, recover reaction product |
| 08/01/2002 | US20020102592 Probing of specific nucleic acids |
| 08/01/2002 | US20020102591 Methods for detection of a target nucleic acid |
| 08/01/2002 | US20020102590 Fluorescent nucleobase conjugates having anionic linkers |
| 08/01/2002 | US20020102589 Microarrays and methods for evaluating activity of compounds having estrogen-like activity |
| 08/01/2002 | US20020102587 Detection of enzyme inhibitors; obtain cell, incubate with modulator/antitumor agents, monitor for reduction in tumor metastasis |
| 08/01/2002 | US20020102586 Massive parallel method for decoding DNA and RNA |
| 08/01/2002 | US20020102585 Prostate growth-associated membrane proteins |
| 08/01/2002 | US20020102584 In-situ hybridization probes for the detection of microsporidial species |
| 08/01/2002 | US20020102583 Method for isolation of extrachromosomal amplified genes |
| 08/01/2002 | US20020102582 Corn event MON810 and compositions and methods for detection thereof |
| 08/01/2002 | US20020102581 Diagnostics and therapeutics for ocular disorders |
| 08/01/2002 | US20020102580 Removal of molecular assay interferences |
| 08/01/2002 | US20020102579 Method for analyzing genomic DNA |
| 08/01/2002 | US20020102577 Generating preferential enzymatic polypeptide; obtain nucleotide sequences coding polypeptide, amplify nucleotide sequences, expess sequences coding polypeptide, recover polypeptide |
| 08/01/2002 | US20020102576 Method of diagnosing pulmonary hypertension |
| 08/01/2002 | US20020102575 For amplification of a nucleic acid molecule using a single primer, under isothermal conditions; kits |
| 08/01/2002 | US20020102574 Probes and methods for detection of nucleic acids |
| 08/01/2002 | US20020102573 Monitoring, detecting, screening and determining pancreatic defects in humans; obtain and determine nucleotide sequence of sample, compare to control, detect mutation, evaluate human for pancreatic defects |
| 08/01/2002 | US20020102572 Mass spectrometric methods for biomolecular screening |
| 08/01/2002 | US20020102571 Nucleotide sequences for use as tools of amplification and hybridization |
| 08/01/2002 | US20020102570 Methods and reagents for preservation of DNA in bodily fluids |
| 08/01/2002 | US20020102569 Nucleotide sequences for use in the detection, classificataions, treatment and evaluation of cancer therapies |
| 08/01/2002 | US20020102568 Nucleic acid sensor molecules |
| 08/01/2002 | US20020102567 Method for comparing nucleic acid sequences |
| 08/01/2002 | US20020102566 Identification of neural defects associated with the nucleosomal assembly protein 112 gene |
| 08/01/2002 | US20020102565 Device for performing an assay, a method for manufacturing said device, and use of a membrane in the manufacture of said device |
| 08/01/2002 | US20020102563 Isolating preferential nucleotide sequences; obtain nucleotide sequences, apply to column, elute preferential nucleotide sequences, recover nucleotide sequences |
| 08/01/2002 | US20020102562 Recombinant CMV neutralizing proteins |
| 08/01/2002 | US20020102561 Expression analysis of rare expressed genes can be obtained by removing abundant genes by mixing and hybridizing said nucleic acid sample with probes, and subsequently recovering nucleic acids not bound to probes |
| 08/01/2002 | US20020102557 Self -complementary molecular probe |
| 08/01/2002 | US20020102556 Genotyping by mass spectrometric analysis of short DNA fragments |
| 08/01/2002 | US20020102554 Hybridization buffers using low molecular weight dextran sulfate and methods for their use |
| 08/01/2002 | US20020102553 Molecular markers for the diagnosis of alzheimer's disease |
| 08/01/2002 | US20020102552 Nucleotide sequences coding preferential polypeptide for use in the treatment of diabetes and eating disorders |
| 08/01/2002 | US20020102550 Detection of blooms disease; obtain tissue sample, incubate with probe which hybridizes to gene associated with blooms disease, the abence of wildtype gene indicates disease |
| 08/01/2002 | US20020102549 Monitor preferential nucleotide sequences in sample; obtain nucleotide sequences, incubate with amplificaion mixture, incubate with priers, recover nucleotide sequences, detect target sequences |
| 08/01/2002 | US20020102548 Controls for use in nucleic acid analysis |
| 08/01/2002 | US20020102541 Determination of genetic sex in equine species by analysis of y-chromosomal dna sequences |
| 08/01/2002 | US20020102540 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 08/01/2002 | US20020102538 Suppressor of HIV replication and transcription |
| 08/01/2002 | US20020102535 Nucleic acid molecules and polypeptides for immune modulation |
| 08/01/2002 | US20020102534 Exhaustive analysis of viral protein interactions by two-hybrid screens and selection of correctly folded viral interacting polypeptides |
| 08/01/2002 | US20020102533 Monitoring activity of viral enzymatic polypeptide; obtain protease, incubate with modulator, monitor adjustment in protease activity |
| 08/01/2002 | US20020102532 Cancer gene determination and therapeutic screening using signature gene sets |
| 08/01/2002 | US20020102531 Detecting modulators of genes associated with cancer; obtain cells, incubate with modulator, detect adjustments in gene expression |
| 08/01/2002 | US20020102530 Detecting modulators of pregancy; obtain cells, monitor expression of syncytin, incubate with modulator, monitor expression of syncytin |
| 08/01/2002 | US20020102276 For diagnosis, therapy and prophylaxis of Neisseria meningitidis infection; vaccine |
| 08/01/2002 | US20020102270 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/01/2002 | US20020102269 Contacting a parental Helicobacter with molecule in biological sample, testing and comparing response to extracellular pH and sensitivity to acidity of parental strain to a strain deficient in UreI; selecting molecule |
| 08/01/2002 | US20020102263 Diagnosis and treatment of malignant neoplasms |
| 08/01/2002 | US20020102252 Novel isoforms of human pregnancy-associated protein-E |
| 08/01/2002 | US20020102250 Recombinant S. aureus peptide deformylase |
| 08/01/2002 | US20020102244 Obtaining a cell sample which contains a stem cell; detecting the expression of BCRP by a cell in the cell sample; wherein a cell that expresses BCRP is identified as a stem cell |
| 08/01/2002 | US20020102210 Treating target organism having a developing gonadal cell responsive to protein with potential modulator(s) of cell migration; observing change in migration or shape of developing gonadal cell attributable to presence of modulator |
| 08/01/2002 | US20020100685 Sample can be introduced into the reaction area in more than one direction and sample demands can be reduced as low as possible |
| 08/01/2002 | DE10103694A1 Verwendung von EST-Sequenzen oder Varianten der Unigene-Cluster HS1, HS2 und/oder HS3 für die Diagnose und Therapie von Tumorerkrankungen sowie therapeutische Mittel Use of EST sequences or variants of Unigene Cluster HS1, HS2 and / or HS3 for the diagnosis and therapy of tumor diseases as well as therapeutic agents |
| 08/01/2002 | DE10102977A1 Testsystem zur Entwicklung von Therapeutika, insbesondere von Wirkstoffen zur Behandlung von Osteoporose Test system for the development of therapeutics, in particular of drugs used to treat osteoporosis |
| 08/01/2002 | DE10102839A1 Verfahren zur Bestimmung hydrolytischer Enzyme Method for determination of hydrolytic enzymes |
| 08/01/2002 | DE10102687A1 Trisomie 13-Diagnostik-Kit Trisomy 13 diagnosis kit |
| 08/01/2002 | DE10100493A1 Nachweis von pathogenen Bakterien Detection of pathogenic bacteria |
| 08/01/2002 | DE10100121A1 Verfahren zur Bestimmung des Hautstreß oder der Hautalterung in vitro A method for determining skin stress or aging of the skin in vitro |
| 08/01/2002 | DE10051564A1 Neue Verfahren zur parallelen Sequenzierung eines Nukleinsäuregemisches an einer Oberfläche New method for parallel sequencing a nucleic acid mixture to a surface |
| 08/01/2002 | CA2792244A1 A method for identification, isolation and production of antigens to a specific pathogen |
| 08/01/2002 | CA2473308A1 Assay and kit for analyzing gene expression |
| 08/01/2002 | CA2467657A1 Process for determining target function and identifying drug leads |
| 08/01/2002 | CA2440703A1 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |